Scholarly Works - Conferences
Conference
Blood
·
November 5, 2024
Introduction: Chimeric Antigen Receptor (CAR)- T cell therapy has revolutionized the treatment of hematologic malignancies. However, access to CAR-T therapy remains limited, especially fo ...
Full text
Cite
Conference
Blood
·
November 5, 2020
Introduction: There is no standard induction therapy in extranodal marginal zone lymphoma (EMZL); current guidelines borrow from follicular lymphoma, where bendamustine and rituximab (BR) is an accepted standard. The data on BR in EMZL is limited ( ...
Full text
Cite
Conference
Clinical Lymphoma Myeloma and Leukemia
·
September 2017
Full text
Cite
Conference
Blood
·
November 15, 2013
AbstractBackgroundThere is ample data for the response rates and clinical outcomes for patients with newly diagnosed multiple myeloma ...
Full text
Cite
Conference
Blood
·
November 15, 2013
AbstractBackgroundAmplification and/or over-expression of the mitotic Aurora A kinase (AAK) have been reported in a variety of tumors. ...
Full text
Cite
Conference
Blood
·
November 16, 2012
AbstractAbstract 1622Background:Contemporary therapy for mantle cell lymphoma (MCL) in fit patients u ...
Full text
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2010
Full text
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2010
Full text
Cite
Conference
Journal of Clinical Oncology
·
May 20, 2008
Full text
Cite